Detalhe da pesquisa
1.
Long-term outcomes of elderly hairy cell leukemia patients treated with cladribine.
Ann Hematol
; 101(5): 1089-1096, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218397
2.
Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series.
Blood
; 123(2): 177-83, 2014 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24192579
3.
Detection of Genomic Structural Variations Associated with Drug Sensitivity and Resistance in Acute Leukemia.
Cancers (Basel)
; 16(2)2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254907
4.
Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine.
Blood
; 115(10): 1893-6, 2010 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-20056789
5.
The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.
Nat Commun
; 12(1): 5397, 2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518534
6.
Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
J Clin Oncol
; 21(5): 891-6, 2003 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12610190